Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference.
RNA interference (RNAi) is an ancient antiviral response that processes dsRNA and associates it into a nuclease complex that identifies RNA with sequence homology and specifically cleaves it. We demonstrate that RNAi mediated by 21-bp dsRNA specifically inhibits HIV-1 infection of permanent cell lines and primary CD4(+) T cells. Inhibition of HIV replication was measured by p24 Gag protein content in supernatant, Northern blot analysis, and DNA PCR for products of reverse transcription. The inhibition occurred at two points in the viral life cycle, after fusion and before reverse transcription and during transcription of viral RNA from integrated provirus. Treatment of HIV-infected activated CD4(+) T cells with a fluorine-derivatized siRNA that is resistant to RNase A yielded similar inhibition of HIV infection. In addition, the derivatized siRNA could be delivered without lipofectin complexing and in the presence of serum. The identification of RNAi activity against HIV-1 presents a new approach to study viral infections and a proof of concept of RNAi antiviral activity in mammalian cells.
Capodici
John
J
Department of Medicine, University of Pennsylvania, Philadelphia 19104, USA.
Karikó
Katalin
K
Weissman
Drew
D
D019380:Anti-HIV Agents / Q000494:pharmacology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000502:physiology / Q000821:virology; D002460:Cell Line / Q000502:physiology / Q000821:virology; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D008213:Lymphocyte Activation / Q000502:physiology; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011533:Proviruses / Q000502:physiology; D012330:RNA, Double-Stranded / Q000494:pharmacology; D012333:RNA, Messenger / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D034741:RNA, Small Interfering / Q000502:physiology*; D012367:RNA, Viral / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000502:physiology*; D014158:Transcription, Genetic / Q000502:physiology; D014162:Transfection; D014407:Tumor Cells, Cultured / Q000502:physiology / Q000821:virology; D014762:Viral Interference / Q000502:physiology*; D014779:Virus Replication / Q000502:physiology
D019380:Anti-HIV Agents; D011500:Protein Synthesis Inhibitors; D012330:RNA, Double-Stranded; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D012367:RNA, Viral